Skip Navigation


JAC Advance Access originally published online on January 16, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
53/2/230    most recent
dkh083v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pag, U.
Right arrow Articles by Sahl, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pag, U.
Right arrow Articles by Sahl, H.-G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2004) 53, 230-239
© 2004 The British Society for Antimicrobial Chemotherapy

In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates

U. Pag1, M. Oedenkoven1, N. Papo2, Z. Oren2, Y. Shai2 and H.-G. Sahl1,*

1 Institut für Medizinische Mikrobiologie und Immunologie der Universität Bonn, D-53105 Bonn, Germany; 2 Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, 76100 Israel

Received 22 September 2003; returned 14 October 2003; revised 19 November 2003; accepted 20 November 2003

Objectives: Increasing resistance of pathogenic bacteria to antibiotics is a severe problem in health care and has intensified the search for novel drugs. Cationic antibacterial peptides are the most abundant antibiotics in nature and have been frequently proposed as new anti-infective agents. Here, a group of diastereomeric (containing D- and L-amino acids) peptides is studied regarding their potency against multiply resistant clinical isolates and their modes of action against Gram-positive cocci.

Methods: MIC determinations and chequerboard titrations followed established procedures. Mode of action studies included killing kinetics and a series of experiments designed to characterize the impact of the diastereomeric peptides on bacterial membranes.

Results: The tested diastereomers displayed high antimicrobial and broad spectrum activity with amphipathic-2D being the most active peptide. Synergic activities were observed with individual strains. Mode of action studies clearly demonstrated that the cytoplasmic membrane is a primary target for the peptides and that membrane disruption constitutes a significant bactericidal activity for the major fraction of a bacterial population. However, depending on the indicator strain, the results also suggest that additional molecular events contribute to the overall activity.

Keywords: synergic activities, membrane permeabilization, intracellular targets

* Corresponding author. Tel: +49-228-287-5704; Fax: +49-228-287-4808; E-mail: sahl{at}mibi03.meb.uni-bonn.de


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. L. Mangoni, R. F. Epand, Y. Rosenfeld, A. Peleg, D. Barra, R. M. Epand, and Y. Shai
Lipopolysaccharide, a Key Molecule Involved in the Synergism between Temporins in Inhibiting Bacterial Growth and in Endotoxin Neutralization
J. Biol. Chem., August 22, 2008; 283(34): 22907 - 22917.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
N. P. Chongsiriwatana, J. A. Patch, A. M. Czyzewski, M. T. Dohm, A. Ivankin, D. Gidalevitz, R. N. Zuckermann, and A. E. Barron
Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides
PNAS, February 26, 2008; 105(8): 2794 - 2799.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
U. Pag, M. Oedenkoven, V. Sass, Y. Shai, O. Shamova, N. Antcheva, A. Tossi, and H.-G. Sahl
Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an {alpha}-helical 'sequence template'
J. Antimicrob. Chemother., February 1, 2008; 61(2): 341 - 352.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Rosenfeld, D. Barra, M. Simmaco, Y. Shai, and M. L. Mangoni
A Synergism between Temporins toward Gram-negative Bacteria Overcomes Resistance Imposed by the Lipopolysaccharide Protective Layer
J. Biol. Chem., September 29, 2006; 281(39): 28565 - 28574.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
I. Chatterjee, G. A. Somerville, C. Heilmann, H.-G. Sahl, H. H. Maurer, and M. Herrmann
Very Low Ethanol Concentrations Affect the Viability and Growth Recovery in Post-Stationary-Phase Staphylococcus aureus Populations
Appl. Envir. Microbiol., April 1, 2006; 72(4): 2627 - 2636.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H.-G. Sahl, U. Pag, S. Bonness, S. Wagner, N. Antcheva, and A. Tossi
Mammalian defensins: structures and mechanism of antibiotic activity
J. Leukoc. Biol., April 1, 2005; 77(4): 466 - 475.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Braunstein, N. Papo, and Y. Shai
In Vitro Activity and Potency of an Intravenously Injected Antimicrobial Peptide and Its DL Amino Acid Analog in Mice Infected with Bacteria
Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3127 - 3129.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.